Fate Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell FATE and other ETFs, options, and stocks.About FATE
Fate Therapeutics, Inc. engages in the development of programmed cellular immunotherapies for cancer and immune disorder. Its pipeline of products includes immuno-ocology candidates and immuno-regulation candidates.
FATE Key Statistics
Stock Snapshot
As of today, Fate Therapeutics(FATE) shares are valued at $2.56. The company's market cap stands at 306.14M, with a P/E ratio of -2.49.
On 2026-08-18, Fate Therapeutics(FATE) stock traded between a low of $2.53 and a high of $2.63. Shares are currently priced at $2.56, which is +0.8% above the low and -2.9% below the high.
The Fate Therapeutics(FATE)'s current trading volume is 561.25K, compared to an average daily volume of 2.81M.
In the last year, Fate Therapeutics(FATE) shares hit a 52-week high of $3.23 and a 52-week low of $0.93.
In the last year, Fate Therapeutics(FATE) shares hit a 52-week high of $3.23 and a 52-week low of $0.93.
FATE News
Reports Q2 revenue $2.08M, consensus $1.27M. “Dosing of the first patient in RECLAIM-LN, our Phase 2 potentially registrational trial, is an exciting milestone...
...
Analyst ratings
50%
of 12 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.